291 related articles for article (PubMed ID: 30483052)
1. The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons
Kumar N; Stanford W; de Solis C; Aradhana ; Abraham ND; Dao TJ; Thaseen S; Sairavi A; Gonzalez CU; Ploski JE
Front Mol Neurosci; 2018; 11():413. PubMed ID: 30483052
[TBL] [Abstract][Full Text] [Related]
2. The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing.
de Solis CA; Ho A; Holehonnur R; Ploski JE
Front Mol Neurosci; 2016; 9():70. PubMed ID: 27587996
[TBL] [Abstract][Full Text] [Related]
3. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
4.
Li Q; Su J; Liu Y; Jin X; Zhong X; Mo L; Wang Q; Deng H; Yang Y
Mol Ther Methods Clin Dev; 2021 Mar; 20():652-659. PubMed ID: 33718515
[TBL] [Abstract][Full Text] [Related]
5. A Split Staphylococcus aureus Cas9 as a Compact Genome-Editing Tool in Plants.
Kaya H; Ishibashi K; Toki S
Plant Cell Physiol; 2017 Apr; 58(4):643-649. PubMed ID: 28371831
[TBL] [Abstract][Full Text] [Related]
6. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population.
Morsy SG; Tonne JM; Zhu Y; Lu B; Budzik K; Krempski JW; Ali SA; El-Feky MA; Ikeda Y
BMC Res Notes; 2017 Dec; 10(1):720. PubMed ID: 29221488
[TBL] [Abstract][Full Text] [Related]
7. A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation.
Zhang Y; Nishiyama T; Li H; Huang J; Atmanli A; Sanchez-Ortiz E; Wang Z; Mireault AA; Mammen PPA; Bassel-Duby R; Olson EN
Mol Ther Methods Clin Dev; 2021 Sep; 22():122-132. PubMed ID: 34485599
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
9. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
Altenbuchner J
Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
[TBL] [Abstract][Full Text] [Related]
10. Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
Fry LE; Peddle CF; Stevanovic M; Barnard AR; McClements ME; MacLaren RE
CRISPR J; 2020 Aug; 3(4):276-283. PubMed ID: 32833533
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus.
Liu Y; Zhao M; Gong M; Xu Y; Xie C; Deng H; Li X; Wu H; Wang Z
Antiviral Res; 2018 Apr; 152():58-67. PubMed ID: 29458131
[TBL] [Abstract][Full Text] [Related]
12. A Self-Deleting AAV-CRISPR System for
Li A; Lee CM; Hurley AE; Jarrett KE; De Giorgi M; Lu W; Balderrama KS; Doerfler AM; Deshmukh H; Ray A; Bao G; Lagor WR
Mol Ther Methods Clin Dev; 2019 Mar; 12():111-122. PubMed ID: 30619914
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CRISPR/Cas Endonucleases for
Li F; Wing K; Wang JH; Luu CD; Bender JA; Chen J; Wang Q; Lu Q; Nguyen Tran MT; Young KM; Wong RCB; Pébay A; Cook AL; Hung SSC; Liu GS; Hewitt AW
Front Cell Neurosci; 2020; 14():570917. PubMed ID: 33132845
[TBL] [Abstract][Full Text] [Related]
14. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
[TBL] [Abstract][Full Text] [Related]
15.
Lau CH; Suh Y
F1000Res; 2017; 6():2153. PubMed ID: 29333255
[TBL] [Abstract][Full Text] [Related]
16. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
17. Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization.
Chung SH; Mollhoff IN; Nguyen U; Nguyen A; Stucka N; Tieu E; Manna S; Meleppat RK; Zhang P; Nguyen EL; Fong J; Zawadzki R; Yiu G
Mol Ther Methods Clin Dev; 2020 Jun; 17():409-417. PubMed ID: 32128346
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
19. Efficient
Ginn SL; Amaya AK; Liao SHY; Zhu E; Cunningham SC; Lee M; Hallwirth CV; Logan GJ; Tay SS; Cesare AJ; Pickett HA; Grompe M; Dilworth K; Lisowski L; Alexander IE
JHEP Rep; 2020 Feb; 2(1):100065. PubMed ID: 32039406
[TBL] [Abstract][Full Text] [Related]
20. In vivo genome editing using Staphylococcus aureus Cas9.
Ran FA; Cong L; Yan WX; Scott DA; Gootenberg JS; Kriz AJ; Zetsche B; Shalem O; Wu X; Makarova KS; Koonin EV; Sharp PA; Zhang F
Nature; 2015 Apr; 520(7546):186-91. PubMed ID: 25830891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]